Skip to main content
Clinical Trials/IRCT20170723035248N4
IRCT20170723035248N4CompletedPhase 3

A Comparative assessment of topical Glucantime® injection plus cryotherapy, and cryotherapy alone for Treatment of Anthroponotic cutaneous leishmaniasis

Ghoum University of Medical Sciences0 sites476 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
476

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 year to no limit (—)
Sex
All

Inclusion Criteria

  • Criteria for joining the study include age over one year
  • Onset of disease in less than 4 weeks.

Exclusion Criteria

  • Criteria for withdrawing from the study include use of antibiotics or other antimicrobial drugs for leishmaniasis in the past 4 weeks
  • Extensive lesions with a diameter of more than 5 cm and more than 3 lesions on the patient's body.

Investigators

Sponsor
Ghoum University of Medical Sciences

Similar Trials